Atlas Trials

Evolution of the SURvival of Patients With SEzary Syndrome (SS) Over the 1998-2020 Period and Its Association With the Early Use of Therapeutic Monoclonal Antibodies

Clinical trial NCT05206045 · UNKNOWN

Trial details

NCT number
NCT05206045
Sponsor
Assistance Publique - Hôpitaux de Paris
Status
UNKNOWN
Study type
OBSERVATIONAL
Sezary SyndromeCutaneous T Lymphoma
Start date
2022-01-01
Primary completion
2022-06-30
Enrollment
700

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.